Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-87P (RNA, U6 small nuclear 87, pseudogene) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a functional gene but typically non-functional due to accumulated mutations preventing its expression as a functional product. It is related by sequence to the functional U6 small nuclear RNA gene, which encodes a core component of the spliceosome complex involved in pre-mRNA splicing. However, RNU6-87P itself does not produce a functional snRNA and is not known to encode any active RNA molecule or protein product. There is no evidence linking RNU6-87P to biological functions, disease association, drug interactions, or biomarker relevance, and it is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 87, pseudogene (RNU6-87P).